Pharmaceutical News and Articles

FDA Approves Grafapex (treosulfan) Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Trump Ends Push To Slash Prescription Drug Costs

With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medic

Study IDs Signs of Topical Steroid Withdrawal in Atopic Dermatitis

Self-reported manifestations of topical steroid withdrawal (TSW) in atopic dermatitis (AD) include erythema, desquamation, dryness, and oozing affecting the fac

ART Pregnancies Have Higher Exposure to Teratogenic Medications

Pregnancies resulting from assisted reproductive technology (ART) have a higher prevalence of exposure to teratogenic medicines, according to a study published

High-Fiber Diets Linked to Gut Health & Fewer Harmful Bacteria

Could eating more fiber be the key to a healthier gut Research suggests the answer is yes. The findings, published recently in the journal Nature Microbiology,

AI Model IDs Women With Subjective Cognitive Decline During Menopause

Machine learning models may be able to identify women with severe subjective cognitive decline (SCD) during the menopause transition, according to a study publi

Trump-Era HHS Website Makes Term ‘Abortion’ Harder To Find

Abortion information is disappearing from federal government websites, signaling potential changes in abortion under the second Trump administration. Reproducti

Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complic

Trump Issues Executive Order Withdrawing U.S. From WHO

In one of his first presidential actions on Monday, President Trump issued an executive order withdrawing the United States from the World Health Organization.

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inade